Cytox in Collaboration with AKESOgen Extends Genetic Test for Assessing Alzheimer’s Risk to Include Saliva Samples

Image may be NSFW.
Clik here to view.

---

PRESS RELEASE: Pioneering PRS approach verified for banked DNA, blood and saliva samples OXFORD, England & MANCHESTER, England & ATLANTA–(BUSINESS WIRE)–May 8, 2018– Cytox, a precision medicine testing company commercializing polygenic risk scoring (PRS) and other approaches for assessing genetic risk for developing Alzhei…Read More